/Companies

Ra Medical Systems

Fort Mill, US · Delaware corporation · 1 known investors

Find your way into Ra Medical Systems

Sign up to find every way you can get introduced to Ra Medical Systems

  • Your email: who you already know at Ra Medical Systems, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ra Medical Systems team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Founders & leadership

DA
David A. JenkinsExecutive
JW
Jonathan Will McGuireExecutive
SP
Steven PasseyExecutive

Board

SM
Susanne MelineBoard director
JC
James CarusoBoard director
MC
Martin ColombattoBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$98M disclosed across 5 rounds · 2016–2023

▶$8MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David A. JenkinsDirector, Executive Officer
  • James CarusoDirector
  • Martin ColombattoDirector
  • Jonathan Will McGuireExecutive Officer, Promoter
  • Susanne MelineDirector
  • Steven PasseyExecutive Officer
Offering amount
$8M
Amount sold
$8M
Sales commissions
$640K
Placement agents
Ladenburg Thalmann & Co., Inc.
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.2MraisedAug 2022 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Susanne MelineDirector
  • Brian ConnExecutive Officer
  • Joan StafslienDirector
  • Martin ColombattoDirector
  • Richard Mejia, Jr.Director
  • Will McGuireExecutive Officer, Director
Offering amount
$6.2M
Amount sold
$6.2M
Sales commissions
$497.3K
Finders' fees
$497.3K
Placement agents
Ladenburg Thalmann & Co. Inc.
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.3MraisedJul 2018 · 64 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey KrawsExecutive Officer
  • Maurice BuchbinderDirector
  • Dean IrwinExecutive Officer, Director
  • Martin BursteinDirector
  • Melissa BursteinExecutive Officer, Director
  • Martin ColombattoDirector
  • Richard HeymannDirector
  • Andrew JacksonExecutive Officer
Offering amount
$5.3M
Amount sold
$5.3M
First sale
Aug 2016
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$60.2MraisedJun 2018 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dean IrwinExecutive Officer, Director
  • Richard HeymannDirector
  • Martin ColombattoDirector
  • Andrew JacksonExecutive Officer
  • Maurice BuchbinderDirector
  • Jeffrey KrawsExecutive Officer
  • Martin BursteinDirector
  • Melissa BursteinExecutive Officer, Director
Offering amount
$60.2M
Amount sold
$60.2M
First sale
Jun 2018
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.3MraisedJun 2018 · 49 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew JacksonExecutive Officer
  • Maurice BuchbinderDirector
  • Martin BursteinDirector
  • Dean IrwinExecutive Officer, Director
  • Jeffrey KrawsExecutive Officer
  • Richard HeymannDirector
  • Martin ColombattoDirector
  • Melissa BursteinExecutive Officer, Director
Offering amount
$19M
Amount sold
$18.3M
First sale
Sep 2017
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Ra Medical Systems's investors?
Ra Medical Systems's investors include Keiretsu Forum.
How much funding has Ra Medical Systems raised?
Ra Medical Systems has disclosed $98M raised across 5 rounds.
Where is Ra Medical Systems headquartered?
Ra Medical Systems is headquartered in Fort Mill, US.